person

Juan José U. P.

Country
Spain
Department
Digestive Service

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
12
Sites with multiple studies

Has run more than one trial at 12 of 95 partner sites.

Specializations

Hepatology & Liver Disease

This investigator specializes in treating complex liver conditions, with particular focus on chronic hepatitis B and hepatocellular carcinoma. Their research encompasses innovative therapeutic approaches for both viral and oncological liver diseases.

  • Chronic Viral Hepatitis Management
  • Liver Cancer Treatment
  • Long-term Disease Monitoring

The investigator explores treatment durability in hepatitis B patients and evaluates novel therapeutic combinations for liver cancer.

Oncology

Specialized in hepatocellular carcinoma treatment, the investigator studies advanced therapeutic combinations including targeted therapy and immunotherapy approaches. Their work focuses on non-metastatic liver cancer cases requiring complex intervention strategies.

  • Combined Modality Treatment
  • Interventional Oncology
  • Treatment Response Assessment

Their research integrates various treatment modalities including local and systemic therapies for optimal patient outcomes.

Interventional Medicine

The investigator has expertise in transarterial chemoembolization (TACE) procedures and their combination with systemic treatments. Their work explores innovative therapeutic combinations for treating liver malignancies.

  • Combination Therapy Approaches
  • Minimally Invasive Procedures
  • Treatment Response Monitoring

Their research evaluates the effectiveness of combined local-systemic treatment strategies in liver disease management.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.